These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6605773)

  • 1. Monoclonal antibodies to myeloid differentiation antigens: in vivo studies of three patients with acute myelogenous leukemia.
    Ball ED; Bernier GM; Cornwell GG; McIntyre OR; O'Donnell JF; Fanger MW
    Blood; 1983 Dec; 62(6):1203-10. PubMed ID: 6605773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid cell-specific monoclonal antibodies.
    Ball ED; Mills LE; Coughlin CT; Beck JR; Cornwell GG
    Blood; 1986 Dec; 68(6):1311-5. PubMed ID: 3535927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
    Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
    Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo efficacy of monoclonal antibody-drug conjugates of three different subisotypes which bind the human tumor-associated antigen defined by the KS1/4 monoclonal antibody.
    Starling JJ; Maciak RS; Hinson NA; Nichols CL; Briggs SL; Laguzza BC
    Cancer Immunol Immunother; 1989; 28(3):171-8. PubMed ID: 2784353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies that bind to the My23 human myeloid cell surface molecule: epitope analysis and antigen modulation studies.
    Maliszewski CR; Currier J; Fisher J; Smith RJ; Fanger MW
    Mol Immunol; 1987 Jan; 24(1):17-25. PubMed ID: 2441245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of antigen-specific immune response with use of anti-idiotypic monoclonal antibodies to anti-carcinoembryonic antigen antibodies.
    Tsujisaki M; Imai K; Tokuchi S; Hanzawa Y; Ishida T; Kitagawa H; Hinoda Y; Yachi A
    Cancer Res; 1991 May; 51(10):2599-604. PubMed ID: 2021940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia.
    Caron PC; Dumont L; Scheinberg DA
    Clin Cancer Res; 1998 Jun; 4(6):1421-8. PubMed ID: 9626458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies against the chronic lymphatic leukemia antigen cCLLa: characterization and reactivity.
    Faguet GB; Agee JF
    Blood; 1987 Aug; 70(2):437-43. PubMed ID: 2440501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody T101 in T cell malignancies: a clinical, pharmacokinetic, and immunologic correlation.
    Bertram JH; Gill PS; Levine AM; Boquiren D; Hoffman FM; Meyer P; Mitchell MS
    Blood; 1986 Sep; 68(3):752-61. PubMed ID: 3488778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.
    Liao SK; Smith JW; Kwong PC; Natali PG; Kusama M; Hamby CV; Ferrone S
    Cancer Res; 1987 Sep; 47(18):4835-41. PubMed ID: 3476198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity patterns of monoclonal antibodies positive on myelomonocytic leukemia cells as defined by esterase isoenzyme analysis.
    Drexler HG; Menon M; Gaedicke G; Minowada J
    Cancer Immunol Immunother; 1986; 21(3):188-92. PubMed ID: 3457629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development and analysis of species specific and cross reactive monoclonal antibodies to leukocyte differentiation antigens and antigens of the major histocompatibility complex for use in the study of the immune system in cattle and other species.
    Davis WC; Marusic S; Lewin HA; Splitter GA; Perryman LE; McGuire TC; Gorham JR
    Vet Immunol Immunopathol; 1987 Jul; 15(4):337-76. PubMed ID: 3114940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NHL-30.5: a monoclonal antibody reactive with an acute myeloid leukemia (AML)-associated antigen.
    Askew DS; Eaves AC; Takei F
    Leuk Res; 1985; 9(1):135-45. PubMed ID: 3857404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
    Andreasen RB; Olsson L
    J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2-23.
    Maliszewski CR; Ball ED; Graziano RF; Fanger MW
    J Immunol; 1985 Sep; 135(3):1929-36. PubMed ID: 3894519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of monoclonal antibodies for the identification and classification of acute myeloid leukemias.
    Drexler HG; Minowada J
    Leuk Res; 1986; 10(3):279-90. PubMed ID: 3512924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I trial of humanized monoclonal antibody HuM195 (anti-CD33) with low-dose interleukin 2 in acute myelogenous leukemia.
    Kossman SE; Scheinberg DA; Jurcic JG; Jimenez J; Caron PC
    Clin Cancer Res; 1999 Oct; 5(10):2748-55. PubMed ID: 10537338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three new monoclonal antibodies that define a unique antigen associated with prolymphocytic leukemia/non-Hodgkin's lymphoma and are effectively internalized after binding to the cell surface antigen.
    Okazaki M; Luo Y; Han T; Yoshida M; Seon BK
    Blood; 1993 Jan; 81(1):84-94. PubMed ID: 8417805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.